Switch to: References

Add citations

You must login to add citations.
  1. Reframing the Debate over Performance-Enhancing Drugs: The Reasonable Athlete Argument.Matthew C. Altman - forthcoming - Sport, Ethics and Philosophy:1-14.
    Governing bodies such as the World Anti-Doping Agency (WADA) and the National Collegiate Athletic Association (NCAA) make decisions about which drugs to prohibit athletes from using and the dosage...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  • Is WADA creating and then prosecuting thought crimes?Jo Morrison & Eric Moore - 2023 - Journal of the Philosophy of Sport 50 (3):402-418.
    Antidoping policy regulates and punishes the use of substances that are listed on a Prohibited List (PL). These substances are colloquially known as ‘performance-enhancing substances’. There is very little empirical evidence of enhancement for most of the substances on the PL raising the possibility that the perceived enhancement of performance experienced by an athlete is a placebo effect. A placebo effect is a response to an inert substance that is strongly influenced by psychological and social cues in the surrounding environment. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  • Anti-Doping Policy, Health, and Harm.Jo Morrison - forthcoming - Sport, Ethics and Philosophy:1-14.
    The anti-doping policies of the World Anti-Doping Agency (WADA) aim to promote a level playing field and protect the health of the athlete. Anti-doping policy discourages research using performance enhancing drugs (PEDs) or methods and prohibits athlete support personnel, including healthcare providers, from providing advice, assistance, or aid to an athlete or others seeking to use, or using PEDs until harm has occurred. Athletes are individually responsible for the presence of a prohibited substance in their bodies and face sanction regardless (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark